| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.100 | Biomarker | disease | HPO | |||||||
|
0.100 | Biomarker | disease | HPO | |||||||
|
0.100 | Biomarker | disease | HPO | |||||||
|
0.100 | Biomarker | disease | HPO | |||||||
|
0.100 | Biomarker | disease | HPO | |||||||
|
0.100 | Biomarker | disease | HPO | |||||||
|
0.100 | Biomarker | disease | HPO | |||||||
|
0.010 | Biomarker | disease | BEFREE | Sample size to detect 60% treatment effect on spinal cord atrophy over 1 year was lower for GBSI than CSA (CIS: 106 vs 830; RRMS: 95 vs 335; PMS: 44 vs 215; power = 80%; alpha = 5%). | 31385358 | 2019 | ||||
|
0.010 | Biomarker | disease | BEFREE | Six weeks after SCI, ionized calcium binding adaptor molecule 1 (Iba1) and glial fibrillary acidic protein (GFAP) expressions were elevated at the lesion epicenter in PRIP1<sup>-/-</sup> mice, and spinal cord atrophy and demyelination were more severe than in WT mice. | 29336201 | 2018 | ||||
|
0.010 | Biomarker | disease | BEFREE | Six weeks after SCI, ionized calcium binding adaptor molecule 1 (Iba1) and glial fibrillary acidic protein (GFAP) expressions were elevated at the lesion epicenter in PRIP1<sup>-/-</sup> mice, and spinal cord atrophy and demyelination were more severe than in WT mice. | 29336201 | 2018 | ||||
|
0.010 | GeneticVariation | disease | BEFREE | We investigated the profile of spinal cord atrophy (SCA) in SMN1-linked SMA, and its correlation with the topography of muscle weakness. | 27089520 | 2016 | ||||
|
0.010 | Biomarker | disease | BEFREE | Hydromyelia and spinal cord atrophy support central nervous system involvement in CMT2A. | 24957169 | 2014 | ||||
|
0.010 | GeneticVariation | disease | BEFREE | Spinal cord atrophy was more severe in SPG6 and SPG8 HSP subjects than in other types of HSP we studied. | 16143870 | 2005 |